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Abstract
The yeast-to-hypha transition plays a crucial role in the pathogenesis of C. albicans. Farnesol, a quorum sensing molecule
(QSM) secreted by the fungal itself, could prevent the formation of hyphae and subsequently lead to the defect of biofilm
formation. The DPP3, encoding phosphatase, is a key gene in regulating farnesol synthesis. In this study, we screened 24
bisbibenzyls and 2 bibenzyls that were isolated from bryophytes or chemically synthesized by using CLSI method for
antifungal effect. Seven bisbibenzyls were found to have antifungal effects with IC80 less than 32 mg/ml, and among them,
plagiochin F, isoriccardin C and BS-34 were found to inhibit the hyphae and biofilm formation of C. albicans in a dose-
dependent manner. To uncover the underlying relationship between morphogenesis switch and QSM formation, we
measured the farnesol production by HPLC-MS and quantified Dpp3 expression by detecting the fluorescent intensity of
green fluorescent protein tagged strain using Confocal Laser Scanning microscopy and Multifunction Microplate Reader.
The DPP3 transcripts were determined by real-time PCR. The data indicated that the bisbibenzyls exerted antifungal effects
through stimulating the synthesis of farnesol via upregulation of Dpp3, suggesting a potential antifungal application of
bisbibenzyls. In addition, our assay provides a novel, visual and convenient method to measure active compounds against
morphogenesis switch.
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Introduction
Candida albicans, which can change from symbiotic form to
pathogenic form upon an alteration in the external environment,
causes shallow surface infections as well as deep infections [1]. In
recent years, the over use of wide-spectrum antibiotics, long and
repeated treatment have caused pathogenic fungi resistant to anti-
fungal agents, especially to fungistatic drugs [2], and thereby more
effective therapeutic drugs or alternative treatments are needed to
alleviate the situation. Studies have demonstrated that filamenta-
tion plays a crucial role in the pathogenic process [3,4,5]. The
transition from yeast to hyphae could improve the virulence of C.
albicans during the course of infection [6]. Filaments generate
strong top pressure for permeation into host body and have the
advantage to escape from immune cells [7]. In addition, hyphae
serving as the skeleton of biofilms play a critical role for the
formation of highly heterogeneous architecture, which protects
microorganisms from antibiotic treatment and also creates a
source of persistent infection [7,8,9]. Therefore, prevention of the
hyphae formation could be an effective means to reduce the
biofilm formation and virulence in the pathogenesis of C. albicans.
Farnesol, a quorum sensing molecule (QSM) secreted by C.
albicans, could inhibit yeast-to-hypha conversion and biofilm
formation [10,11,12,13]. Some antifungal agents could stimulate
farnesol production through inhibiting sterol synthesis in fungi
[14]. DPP3, encoding phosphatase, has been demonstrated to be
involved in farnesol synthesis by converting farnesyl pyrophos-
phate to farnesol [15].
Bisbibenzyls, a group of phenolic compounds exclusively
occurred in liverwort, have potent bioactivities serving as
antifungal, antioxidant and antitumor compounds [16]. We have
previously shown that plagiochin E (A6) [17] extracted from
Marchantia polymorpha could reverse fungal resistance to fluconazole
and induce apoptosis of C. albicans; Riccardin D (A4) [18] from
Dumortiera hirsute inhibits hyphae formation and thereby interfere
with the biofilm formation. In the present experiments, 24
bisbibenzyls and 2 bibenzyls extracted from liverwort plants or
chemically synthesized were screened for antifungal activity. We
found three compounds with good antifungal activities that
displayed bioactivity against hyphae formation. We also measured
Dpp3 expression using GFP-tagged Candida albicans strain
(BWP17-DPP3-GFP) to investigate the underlying relationship
between morphogenesis switch and QSM formation. We showed
that PLF (A1), isoriccardin C (A3) and BS-34 (A5) inhibits hyphal
and biofilm formation in a dose-dependent manner, which was
consistent with the elevated farnesol production and Dpp3
expression. The findings suggest that the tested agents could
inhibit yeast-to-hypha transition by stimulating farnesol produc-
tion through upregulating Dpp3, and thus leading to the failure of
biofilm formation.
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Media and strains
C. albicans strains BWP17 [19], SC5314 [20], CA2 [21], CA10
[22] and YEM30 [23] were used in MIC80 detection, and the
transformant of BWP17 (BWP17-DPP3-GFP) was used throughout
the studies, stored at 280uC. The C. albican strain SC5314 and
YEM30 are wild types, CA2 is a clinical azole-sensitive strain
while CA10 is clinical azole-resistant [18]. BWP17-DPP3-GFP was
constructed by transforming GFP into the strain of BWP17. The
strains were grown in yeast extract peptone dextrose (YPD, 2%
tryptone, 1% yeast extract, 2% glucose) solid medium containing
2% agar, and subcultured overnight to stationary phase with
shaking at 30uC in YPD medium at least twice. Cells were
harvested and washed twice in sterile water and re-suspended in
RPMI 1640 medium plus morpholinepropanesulfonic acid
(MOPS) and adjusted to the desired density after counting with
a hematocytometer.
Antifungal agents
The compounds were naturally isolated from liverwort in our
laboratory except the synthesized compounds including A1, A6,
plagiochin G (A8), polymorphatin A (A9), plagiochin H (A11) and
isoriccardin D (A17) (Fig. 1). All the compounds were diluted with
Figure 1. Chemical structures of bisbibenzyls tested in the antifungal screen. Marked in red were the ones used for further research.
doi:10.1371/journal.pone.0028953.g001
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stored at 220uC. Final desired concentration was diluted with
RPMI 1640 medium.
Construction of green fluorescent protein tagged strain
The C. albicans DPP3-GFP strain (MG1000) was created by
homologous recombination of green fluorescent protein (GFP)
sequences into the 39 end of the DPP3 open reading frame (ORF).
The DNA used for the transformation was created by PCR using
primers containing ,70 base pairs of sequence homologous to the
39 end of the DPP3 open reading frame to amplify a cassette
containing GFP and a URA3 selectable marker using pGFP-
URA3 as the template [24]. The DPP3-GFP fragment was





AGTATCTAGAAGGACCACCTTTGATTG-39). The PCR pro-
duct was transformed into auxotrophic mutant strain BWP17. The
transformed strain was then spotted on SD minus uracil (SD 2
Ura) solid medium and grown at 37uC for 3 d. The colonies
resulting from the transformation were then screened for GFP-
positive cells by fluorescent microscopy.
Antifungal susceptibility study
The minimal inhibitory concentration (MIC) of the tested
agents were determined by the broth microdilution procedure
recommended by the Clinical and Laboratory Standards Institute
(formerly the National Committee for Clinical Laboratory
Standards) [25]. Cells were cultured in 96-wells plate at a density
of (3–5)610
3 cells/ml. The yeast suspension was treated with the
tested agents on several concentrations with two-fold increase,
while the negative control was conducted with the same amount of
vehicle. Testing of these compounds was performed in duplicate
and incubated for 24 h at 35uC.
Anti-hyphal and biolfilm inhibition test
The measurement of hyphal growth was carried out with a
modified broth micro-dilution method [18], cells were diluted with
RPMI 1640 to 10
5 cells/ml, and then the tested agents were added
into the yeast suspension to reach the final concentration ranging
from 0–64 mg/ml with 2-fold increase. They were incubated at
37uC and photographed at indicated time. And the fluorescence
images were captured with the same exposure time. The
morphology of C. albicans cells was assessed directly by microscopy
analysis. To detect hyphae formation on solid media [26], Spider
(1% [wt/vol] nutrient broth, 1% [wt/vol] mannitol, 0.2% [wt/vol]
K2HPO4, with pH 7.2) agar plates containing different concen-
trations of A1, A3 and A5 (Fig. 1) (ranging from 8 mg/ml to
64 mg/ml with 2-fold increase) were used to test morphology
alteration of BWP17-DPP3-GFP cells, the images were captured
from 2 d to 5 d using the 46objectives of an inverted fluorescent
microscope. The effect of identified agents on biofilm formation
were performed as previously described [27]. The final volume of
150 ml of yeast suspension with initial cell density of 1610
6 cells/
ml was seeded into microtiter plates with various concentrations
(0, 4, 8, 16, 32 and 64 mg/ml) of the compounds. 48 hours later,
the supernatant was discarded, the biofilm was washed with sterile
water at least three times to remove the planktonic cells, and then
subject to XTT reduction assay [28]. Testing of these compounds
was performed in quadruplicate. Besides, a visualized way was
utilized for biofilm detection. The supernatant of performed
biofilms was discarded and 100 ml PBS plus 10 ml alamar blue was
added into the well, and then the color change was photographed
after 4–6 hours’ incubation in dark.
Measurement of farnesol using HPLC-MS
In each group, thirteen milliliters of yeast suspension with
concentration of 10
5 cells/ml, was treated with the tested agents at
the final concentration of 26MIC, 16MIC, 0.56MIC and 0 mg/
ml, and incubated at 37uC with shaking. Cells were harvested after
12 hours. The cell debris was dried and weighed with an electronic
balance. Farnesol was extracted as previously described [29] and
detected using HPLC-MS (LCMS-2020, SHIMADZU). The
detection was performed with absorbance at 210-nm and a 5-mm
C18 reversed-phase column (4.6 by 250 mm) was utilized with a
mobile phase of 4:1 methanol-H2O eluted at 1 ml/min flow rate. In
ordertoobtainthestandard curveforfiguring outthe concentration
of farnesol secreted by C. albicans cells, six farnesol standard samples
with different concentrations were applied to receive the integral
areas eluting at its retention time. The farnesol extracted from the
supernatant of each sample was calculated based on the HPLC
integral area compared with standard curve.
Detection of Dpp3 production using Confocal Laser
Scanning microscopy and Multifunctional Microplate
Reader
The Dpp3 expression was measured by detecting the fluorescent
intensity of BWP17-DPP3-GFP strain with Confocal Laser
Scanning microscopy (CLSM). C. albicans cells were cultured at
37uC and treated with different concentrations of the tested agents
or fluconazole (FLC) (positive control). 12 hours later, the images
were captured by CLSM and the fluorescence of GFP was excited
by the laser of 488 nm with emission of 500–560 nm. The
fluorescent intensity of the sample was also measured using a
Multifunctional Microplate Reader (Berthold Biotechnologies,
Bad Wildbad, Germany). Here the GFP was used as a marker
for Dpp3 expression.
DPP3 expression detected by Real-Time Reverse
Transcription Polymerase Chain Reaction (RT-PCR)
BWP17-DPP3-GFP cells were adjusted to 5610
6 cells/ml with
RPMI 1640 medium, 5 ml of cells were incubated with A1 and A3
(32 mg/ml, 16 mg/ml and 8 mg/ml) and A5 (64 mg/ml, 32 mg/ml
and 16 mg/ml) with vehicle as control at 37uC for 12, 24 and
48 hours. The total RNAs were isolated as previously described
[30]. GSP1 was used as the internal control. Measurement of the
relative quantitative expression of DPP3 levels was conducted
through using an Eppendorf Mastercycler Real Time PCR




Values are mean6standard deviation (SD). Statistical signifi-
cances were determined by Student’s t-test and statistical
significance was determined by p,0.05.
Results
In vitro antifungal activity
MIC80 test in RPMI 1640 medium with BWP17-DPP3-GFP
strain showed that A1–A5 were 16 mg/ml, A6 and A7 were
32 mg/ml, A8–A10 were 64 mg/ml, respectively and the remain-
ing were all greater than 64 mg/ml. Three (A1, A3 and A5) of
them were selected to detect the MIC80 using other four C. albicans
strains (Table 1) for further study.
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formation
We next evaluated the activity of A1, A3 and A5 against
morphological conversion and biofilm formation of C. albicans.C e l l s
of BWP17-DPP3-GFP were cultured in RPMI 1640 medium or
Spider agar plates containing gradient concentrations of agents at
37uC and then observed at indicated time under fluorescent
microscope (Olympus IX71, Olympus, Tokyo, Japan). A1, A3 and
A5 at the concentration of 16 mg/ml, completely inhibited hyphal
formation in liquid RPMI 1640 medium within 12 hours and on
Spider agar plates within 5 days (Fig. 2). The inhibitory effects were
shown in a dose-dependent manner. A1 was chosen as an example
toshowthe fungal morphologicalchangeasthetimeelapses.During
12 hours in liquid RPMI 1640 medium, cells were treated with
16 mg/mlofA1maintainedtheyeastformwithonlyaslightincrease
in the number. A suboptimal concentration of A1 (8 mg/ml)
inhibited the hyphae growth but had no effect on germ tube
formation. By contrast, cells in the negative control group formed
the true hyphae after three hours and the filaments formed a criss-
cross network architecture after 9 hours (Fig. 2 A). On Spider agar
plates, the morphology of the colony was photographed from 2 to 5
days using 46objective of an inverted fluorescent microscope. A1 at
its MIC could block the yeast-to-hypha transition revealed by the
colony that showed a very smooth round plaque without mycelium
around the edges throughout the fivedays. When the dose of A1 was
reducedtohalfofitsMIC,thehyphaegrowthcould onlybepartially
inhibited. However, the negative control formed hyphae within 3
days(Fig.2 B).Collectively,the datasuggested the compounds could
completely block the morphogenesis switch at the concentration of
one MIC, and reduce the hyphae growth at half of the MICs.
Biofilm formed by BWP17-DPP3-GFP was monitored by CLSM
and its metabolism activity was evaluated using XTT reduction
assay. The XTT results showed the biofilm inhibitory effect
displayed a dose-dependent manner in the presence of detected
agents. A1 and A3 reduced biofilm formation by about eighty
percent at 32 mg/ml. And the biofilm mass was reduced to sixty
percent by A5 at 32 mg/ml, approximately thirty percent at
64 mg/ml (Fig. 3A). CLSM analysis showed that cells within
treated biofilm displayed yeast morphology when the concentra-
tion of A1 was 32 mg/ml or above. When the dose of A1 was
reduced to 16 mg/ml or in control group, the biofilm predomi-
nantly composed of hyphae was formed (Fig. 3 B). We also utilized
an alamar blue assay to evaluate the efficacy of compounds that
inhibit the biofilm formation. The assay supported the conclusion
that A1 (32 mg/ml or above) inhibited the biofilm formation,
demonstrated by the blue color (Fig. 3 C). When the organism
increased, the color changed from blue to pink as shown in low
doses of A1 treated or negative control groups (Fig. 3 C).
Enhancement of farnesol production by the tested
compounds
To uncover the underlying mechanism of the tested agents in
regulating the morphogenesis, we examined farnesol secreted by
C. albicans by using HPLC-MS. Cells treated with the tested agents




BWP17-DPP3-GFP 16 16 16
SC5314 16 16 16
CA2 16 32 32
C A 1 0 1 61 61 6
YEM30 16 16 16
doi:10.1371/journal.pone.0028953.t001
Figure 2. Phase-contrast micrographs of BWP-DPP3-GFP cells
challenged by bisbibenzyls compounds within 12 hours. A)
Candida albicans cells grown in RPMI 1640 broth medium was captured
using an Olympus fluorescent microscope. The results showed that cells
co-incubated with A1 (16 mg/ml) displayed yeast cells, cells with no
drugs formed mycelium after three hours and maintained substantial
growth of hyphae. B) Cells grown on Spider solid media were
photographed from 2 d to 5 d using 46 objectives of an Olympus
fluorescent microscope.
doi:10.1371/journal.pone.0028953.g002
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time of farnesol was at 20.29 min (Fig. 4 A). The peak eluting at
20.29 min was subjected to MS and showed a molecular ion of m/
z 221.2 and 222.2, which further confirmed the evidence of
farnesol (Fig. 4 B). The farnesol production increased as the dose
of agents rose (Fig. 4 C). At 26 MIC, A1, A3, A5 stimulated
farnesol production by 27.9, 12.7 and 6.9-fold increases,
respectively, compared with that in negative control. The farnesol
production showed 5, 3.3, and 3.1-fold increase at 16MIC, and
3.1, 3, and 2.6 fold-increase at 0.56 MIC, respectively. The
positive control (FLC) could only promote the production of
farnesol by 4.6, 4.2 and 1.9-fold respectively, at 26MIC, 16MIC
and 0.56MIC (Fig. 4 C).
Dpp3 and DPP3 expression induced by the tested agents
Given the results of farnesol production, we next utilized
BWP17-DPP3-GFP strain to detect the expression of Dpp3, an
enzyme converting farnesyl pyrophosphate to farnesol. The
fluorescent intensity of GFP, as the indicator of Dpp3 expression,
was measured by CLSM as well as Multifunctional Microplate
Reader. CLSM analysis suggested Dpp3 expression displayed a
dose-dependent manner under the treatment of tested agents after
the cells were incubated for 12 hours at 37uC. The Dpp3
expression was augumented by A1 with almost 3.7-fold at 8 mg/
ml, 4.7-fold at 16 mg/ml and 7.3 –fold at 32 mg/ml compared with
control (Fig. 5 A, B). The results obtained from Multifunctional
Microplate Reader also showed that the tested agents promoted
the expression of Dpp3 in biofilm. Fluorescent intensity of cells
exposed to A1, A3 and A5 from 64 mg/ml to 8 mg/ml showed a
downward trend, while the biofilm formation changed from
scattered form to mature one, suggesting that Dpp3 expression was
negatively correlated with biofilm formation (Fig. 5 C). To
determine whether the agents regulate Dpp3 in transcriptional
level, we measured DPP3 expression with real-time PCR and
showed DPP3 mRNA could be induced by the tested agents when
the cells were cultured for 12 to 48 h, suggesting the antifungal
activity of the tested compounds by upregulation of DPP3
expression (Fig. 6).
Discussion
As the earliest land plants, bryophytes grow in an unfavorable
environment and inevitably produce secondary metabolites
against different surviving stresses [31]. Among those diverse suite
of fungi interacts with bryophytes as pathogens, which exhibit
different methods of host cell disruption such as invading the host
cell by hyphae formation or causing host protoplast degeneration
[32]. Previous studies suggest these plants could biosynthesize
some chemicals to control the plant diseases caused by fungi or
bacteria [1].
C. albicans, as a pathogenic fungal, switches from yeast
morphotype to filaments and develop the formation of biofilm to
colonize in the host. Based on the aforementioned property of
bryophytes, we evaluated the antifungal activity of their extracts.
Our lab previously reported that bisbibenzyls including plagiochin
E and riccardin D derived from bryophytes displayed a moderate
antifungal action [33,34]. We presume bisbibenzyls are the active
agents in bryophytes to combat fungal invasion. In our present
study, 26 bisbibenzyls isolated from liverworts and chemical
synthesizes were screened for antifungal activities. Among them
three compounds (A1, A3 and A5) showed a good effect in
inhibiting the transition of yeast-to-hypha and biofilm formation
(Fig. 2, 3). The effects of these compounds against biofilm
formation were observed at or above their MICs. And they were
the combination result of inhibitory growth and retarded the yeast
to hyphal transition. Farnesol, a QSM, was found to regulate the
morphogenesis switch and the inhibitory effect was positively
correlated with farnesol formation as detected by HPLC-MS
(Fig. 4). When the farnesol production was divided by the volume
of culture, the concentration of farnesol could reach to 2.44–
14.38 mM. At these concentrations, exogenous added farnesol
could partially inhibit the hyphae formation or growth of C.
albicans [13], but the inhibitory effect is less than that displayed by
Figure 3. Biofilm formed of BWP17-DPP3-GFP cells pretreated with bisbibenzyls compounds. A) Quantitative measurement of inhibition
of biofilm formation with Microplate Reader. B) Confocal micrographs of BWP17-DPP3-GFP cells cultured in RPMI 1640 for 48 hours. C) Cells were
stained with alamar blue and cultured for 4–6 hours in dark, the supernatant would become pink when cells grow into biofilm, otherwise turn into
blue. The test was performed in quadruplicate. A11 represents the compounds that biofilm inhibitory activity .64 mg/ml, bk represents blank control
and nk represents negative control.
doi:10.1371/journal.pone.0028953.g003
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better action of endogenous farnesol. DPP3 encodes phosphatase
which converts farnesyl pyrophosphate to farnesol [15]. To
determine whether the agents stimulated farnesol production by
upregulation of Dpp3, C. albicans strain BWP-DPP3-GFP was
constructed. The results obtained from CLSM and a Multifunc-
tional Microplate Reader showed Dpp3 was stimulated by the
above agents, which was in accordance with the enhanced farnesol
production (Fig. 5). To further investigate whether the upregula-
tion of Dpp3 was the result of DPP3 variation in transcript level,
real-time PCR was performed. The results suggested that DPP3
expression of C. albicans cells was promoted by the tested agents
throughout the 48 h culture (Fig. 6), Based on above analysis, we
concluded that the above agents induced the expression of DPP3
encoding Dpp3, which synthesized more farnesol, to regulate
hyphae and biofilm formation.
The clinical used antifungal agents were discovered based on
killing the cells, at least inhibiting the growth. Azoles displayed
fungistatic action by reducing the sterol synthesis; Echinocandins
inhibit b-glucan synthase to synthesize the cell wall component
and then kill the fungal cells; Rapamycin exerts its antifungal
action by targeting the kinase Tor; Icofungipen functions as tRNA
Figure 4. Farnesol production of BWP17-DPP3-GFP cells stim-
ulated by bisbibenzyls. The cells were pretreated with A1, A3, A5
and FLC at 37uC for 12 hours and the farnesol amounts were
determined by HPLC-MS. A) The retention time of farnesol eluting at
20.29 min. B) MS profile showed a molecular ion of m/z 221.2 and 222.2.
C) Values of ordinate represents the increased folds of farnesol treated
by tested agents compared with control.
doi:10.1371/journal.pone.0028953.g004
Figure 5. Dpp3 expression levels of BWP17-DPP3-GFP cells
induced by bisbibenzyls. Values represent the increased folds of
Dpp3 treated by tested agents compared with control. A) and B) Cells
were treated with A1 and FLC at 37uC for 12 hours and then observed
by CLSM and the Dpp3 expresson was quantitatively measured based
on the fluorescence intensity. C) Fluorescence intensity of C.albicans
cells pretreated with the tested agents was measured using a
Multifunctional Microplater Reader after biofilm formation.
doi:10.1371/journal.pone.0028953.g005
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agents targeting the virulence were less developed, although
related genes of virulence were well investigated [36]. In this study,
we investigated the application of bisbibenzyls against fungal
invasion through regulating the known molecular mechanism of
morphogenesis switch. Moreover, the structure of each active
chemical agent gives a clue for further modification.
Taken together, we provided an alternative way to combat
pathogenic fungi infection by targeting the step of morphogenesis
switch. In addition, an effective assay for screening potential
antifungal agents targeting farnesol synthesis is established through
evaluating hyphal and biofilm formation by measuring Dpp3
expression and farnesol production.
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